Monday, October 26, 2026 · Daily editionET --:--:--

United Kingdom1 robot tracked

Smith+Nephew

Smith+Nephew makes CORI Surgical System, which is at stage 5 of 5: regulator-cleared or mass market.

Website: smith-nephew.com
Based in: United Kingdom
Latest milestone: 8 June 2026

01Robots

What Smith+Nephew makes

Each robot's stage is worked out from its dated, sourced milestones by the same published rules, whoever the maker is.

CORI Surgical SystemMedical · Handheld knee surgery robotStage 5 of 5 · Regulator-cleared or mass marketCORI is a handheld robotic tool that helps surgeons shape bone during knee replacement. It uses a 3D picture of the knee made during surgery to guide the cut.Sold to hospitals and outpatient surgery centers in the US, Europe, Australia and New Zealand, India and Canada.The full record

02Track record

Every dated event

8 June 2026Milestone
Smith+Nephew reported the first operations with CORI XT, a new version built for hospitals and outpatient surgery centers. The first knee cases were done at NYU Langone Health.
MassDevice, 8 June 2026Company-reported
Feb 2026Milestone
Surgeons at Duke Health did the first shoulder replacement operations with CORI.
MassDevice, 3 Mar 2026Company-reported
2025Milestone
Smith+Nephew said 2025 was a record year for CORI sales to hospitals worldwide.
OrthoWorld, 5 Mar 2026Company-reported
26 Sept 2022Regulator
CORI won FDA 510(k) clearance for revision knee surgery (redoing an earlier knee replacement), and the first such cases were done.
MassDevice, 26 Sept 2022Company-reported
23 Nov 2021Milestone
A year after the US launch, CORI went on sale in Europe, Australia and New Zealand, India and Canada. It is smaller and faster than the company's older Navio robot.
MassDevice, 24 Nov 2021Company-reported
14 July 2020Milestone
Smith+Nephew launched CORI for knee surgery in the US.
The Robot Report, 14 July 2020Company-reported
14 Feb 2020Regulator
The FDA cleared the CORI system through the 510(k) route (K193120, maker Blue Belt Technologies, part of Smith+Nephew).
The Robot Report, 14 July 2020 (FDA record K193120, decided 14 Feb 2020)

03Money

On the stock market

Smith+Nephew trades as SN. on LSE and SNN on NYSE. Smith+Nephew notice of results (RNS), 23 July 2026

All robot stocks, funding and suppliers

Prices by TradingView, about 15 minutes delayed. Not investment advice.